Euroapi S.A
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that uses solid phase chemistry;… Read more
Euroapi S.A (EAPIF) - Total Liabilities
Latest total liabilities as of June 2025: $488.40 Million USD
Based on the latest financial reports, Euroapi S.A (EAPIF) has total liabilities worth $488.40 Million USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Euroapi S.A - Total Liabilities Trend (2019–2024)
This chart illustrates how Euroapi S.A's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Euroapi S.A Competitors by Total Liabilities
The table below lists competitors of Euroapi S.A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Race Oncology Limited
PINK:RAONF
|
USA | $1.92 Million |
|
St.Shine Optical Co Ltd
TWO:1565
|
Taiwan | NT$1.71 Billion |
|
Finwise Bancorp
NASDAQ:FINW
|
USA | $783.94 Million |
|
Wonderla Holidays Limited
NSE:WONDERLA
|
India | ₹1.36 Billion |
|
Admicom Oyj
HE:ADMCM
|
Finland | €5.98 Million |
|
DAE-IL Corporation
KO:092200
|
Korea | ₩551.84 Billion |
|
Three Stars NM
SHG:603578
|
China | CN¥3.55 Billion |
|
Zhejiang Taitan Co Ltd
SHE:003036
|
China | CN¥1.53 Billion |
Liability Composition Analysis (2019–2024)
This chart breaks down Euroapi S.A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.53 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.51 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.34 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Euroapi S.A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Euroapi S.A (2019–2024)
The table below shows the annual total liabilities of Euroapi S.A from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $506.00 Million | -26.09% |
| 2023-12-31 | $684.60 Million | +9.38% |
| 2022-12-31 | $625.90 Million | +3.11% |
| 2021-12-31 | $607.00 Million | -0.75% |
| 2020-12-31 | $611.60 Million | +9.49% |
| 2019-12-31 | $558.60 Million | -- |